Physician profile
Miguel Bryce
NPI 1558398784
$13,568.83
in general payments reported to CMS, 2019-2025
18 companies · $1,274 in 2025
The $1,274 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,202 · 2020: $889 · 2021: $1,131 · 2022: $1,425 · 2023: $1,992 · 2024: $2,655 · 2025: $1,274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,260 · Travel and Lodging: $2,654 · Education: $7.51.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,259.64 |
| Travel and Lodging | $2,654.12 |
| Education | $7.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $4,180.71 | 2019-2020 | |
| Medtronic, INC. | $3,941.29 | 2021-2025 | Linq II, Micra, Selectsecure |
| Abbott Laboratories | $2,465.32 | 2019-2025 | Aveir, Ensite Precision |
| Boston Scientific Corporation | $775.29 | 2019-2025 | Watchman Flx, General - Therapies, Lux-Dx Insertable Cardiac Monitor |
| Cvrx, INC. | $527.89 | 2019-2023 | Barostim Neo System |
| Impulse Dynamics (USA) INC. | $311.40 | 2021-2022 | |
| Kestra Medical Technology Services, INC. | $273.57 | 2022-2025 | Assure Wcd |
| Zoll Respicardia, INC. | $223.16 | 2022 | |
| Janssen Pharmaceuticals, INC | $220.58 | 2019-2022 | |
| Abiomed | $193.04 | 2021-2024 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.70 | 2022 | |
| Bardy Diagnostics, INC. | $89.50 | 2021-2022 | |
| Penumbra, INC. | $73.14 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $70.91 | 2023 | Opsumit, Uptravi |
| Merck Sharp & Dohme LLC | $34.40 | 2021-2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $25.86 | 2022 | |
| Baxter Healthcare | $24.67 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Astrazeneca Pharmaceuticals Lp | $13.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miguel Bryce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.